FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W955105219> ?p ?o ?g. }

• W955105219 endingPage "267" @default.
• W955105219 startingPage "259" @default.
• W955105219 abstract "Opioid use in the management of chronic pain is widespread in chronic pain settings. Opioid prescriptions for non-cancer pain and overall opioid sales have been soaring with the increasing nonmedical use of opioids in the United States. Prolonged use of high dose opioids has been associated with adverse consequences including tolerance, abuse, addiction, hyperalgesia, hormonal effects, and immunosuppression. Studies of high dose therapy have shown pain relief with a 30% decrease in the intensity of pain and that only 44% of the patients continue the treatment between 7 and 24 months. However, there is no data available on the prevalence of side effects associated with low or moderate dose opioid use in chronic non-cancer pain when administered in conjunction with interventional techniques.To evaluate the prevalence of side effects, of low or moderate dose opioid therapy with or without benzodiazepines, antidepressants, and their combinations.The evaluation was conducted by interviewing 1,000 patients on stable doses of opioids, with or without benzodiazepines, antidepressants, and their combinations. Patients were categorized into 4 groups with Group 1 receiving opioids only (n = 143), Group 2 receiving opioids and benzodiazepines (n = 159), Group 3 receiving opioids and antidepressants (n = 113), and Group 4 received opioids, benzodiazepines, and antidepressants (n = 118).Inclusion criteria was met in 533 patients receiving opioid therapy for longer than 6 months. The incidence of side effects in Group 1 was 18%, in Group 2 was 8%, in Group 3 was 17%, and in Group 4 was 14%. The most frequent complications were in patients receiving methadone (52%) followed by oxycodone (41%) and morphine (36%). Patients receiving hydrocodone had the least incidences of side effects with 7.5%. There were no significant differences noted based on the duration of therapy, age of the patient, and gender. Severe side effects accounted for only 14 of 137 instances.Limitations of this study include the inability to incorporate multiple other drugs due to complicated nature with multiple groups and data collection and analysis. The other limitation is that the proportion of patients receiving methadone, oxycodone, morphine, and propoxyphene was low compared to hydrocodone with 77% of the patients.Moderate or low dose opioid therapy in conjunction with or without benzodiazepines, antidepressants, or in combinations are associated with minor side effects." @default.
• W955105219 created "2016-06-24" @default.
• W955105219 creator A5037291100 @default.
• W955105219 date "2009-01-14" @default.
• W955105219 modified "2023-10-14" @default.
• W955105219 title "Prevalence of Side Effects of Prolonged Low or Moderate Dose Opioid Therapy with Concomitant Benzodiazepine and/or Antidepressant Therapy in Chronic Non-Cancer Pain" @default.
• W955105219 cites W142954314 @default.
• W955105219 cites W149362916 @default.
• W955105219 cites W160124008 @default.
• W955105219 cites W171278648 @default.
• W955105219 cites W183596989 @default.
• W955105219 cites W1968105689 @default.
• W955105219 cites W1974735423 @default.
• W955105219 cites W199724056 @default.
• W955105219 cites W2000328742 @default.
• W955105219 cites W2017613227 @default.
• W955105219 cites W2022654991 @default.
• W955105219 cites W2029368405 @default.
• W955105219 cites W2033757064 @default.
• W955105219 cites W2054317009 @default.
• W955105219 cites W2055653516 @default.
• W955105219 cites W2059291642 @default.
• W955105219 cites W2093112693 @default.
• W955105219 cites W2104258796 @default.
• W955105219 cites W2143221646 @default.
• W955105219 cites W2159848846 @default.
• W955105219 cites W2160172135 @default.
• W955105219 cites W2176833613 @default.
• W955105219 cites W2237157812 @default.
• W955105219 cites W2276297386 @default.
• W955105219 cites W2403993890 @default.
• W955105219 cites W2410616974 @default.
• W955105219 cites W2413571799 @default.
• W955105219 cites W2415641089 @default.
• W955105219 cites W2418843648 @default.
• W955105219 cites W2568896786 @default.
• W955105219 cites W67220348 @default.
• W955105219 cites W7838549 @default.
• W955105219 cites W79385364 @default.
• W955105219 cites W93832398 @default.
• W955105219 cites W98768606 @default.
• W955105219 cites W2598345836 @default.
• W955105219 doi "https://doi.org/10.36076/ppj.2009/12/259" @default.
• W955105219 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19165308" @default.
• W955105219 hasPublicationYear "2009" @default.
• W955105219 type Work @default.
• W955105219 sameAs 955105219 @default.
• W955105219 citedByCount "37" @default.
• W955105219 countsByYear W9551052192012 @default.
• W955105219 countsByYear W9551052192013 @default.
• W955105219 countsByYear W9551052192014 @default.
• W955105219 countsByYear W9551052192015 @default.
• W955105219 countsByYear W9551052192016 @default.
• W955105219 countsByYear W9551052192019 @default.
• W955105219 countsByYear W9551052192021 @default.
• W955105219 crossrefType "journal-article" @default.
• W955105219 hasAuthorship W955105219A5037291100 @default.
• W955105219 hasBestOaLocation W9551052191 @default.
• W955105219 hasConcept C118552586 @default.
• W955105219 hasConcept C121608353 @default.
• W955105219 hasConcept C126322002 @default.
• W955105219 hasConcept C170493617 @default.
• W955105219 hasConcept C197934379 @default.
• W955105219 hasConcept C2776029756 @default.
• W955105219 hasConcept C2778904085 @default.
• W955105219 hasConcept C2779384505 @default.
• W955105219 hasConcept C2781063702 @default.
• W955105219 hasConcept C2781118164 @default.
• W955105219 hasConcept C42219234 @default.
• W955105219 hasConcept C71924100 @default.
• W955105219 hasConceptScore W955105219C118552586 @default.
• W955105219 hasConceptScore W955105219C121608353 @default.
• W955105219 hasConceptScore W955105219C126322002 @default.
• W955105219 hasConceptScore W955105219C170493617 @default.
• W955105219 hasConceptScore W955105219C197934379 @default.
• W955105219 hasConceptScore W955105219C2776029756 @default.
• W955105219 hasConceptScore W955105219C2778904085 @default.
• W955105219 hasConceptScore W955105219C2779384505 @default.
• W955105219 hasConceptScore W955105219C2781063702 @default.
• W955105219 hasConceptScore W955105219C2781118164 @default.
• W955105219 hasConceptScore W955105219C42219234 @default.
• W955105219 hasConceptScore W955105219C71924100 @default.
• W955105219 hasIssue "1;1" @default.
• W955105219 hasLocation W9551052191 @default.
• W955105219 hasLocation W9551052192 @default.
• W955105219 hasOpenAccess W955105219 @default.
• W955105219 hasPrimaryLocation W9551052191 @default.
• W955105219 hasRelatedWork W2037059059 @default.
• W955105219 hasRelatedWork W2093703536 @default.
• W955105219 hasRelatedWork W2390600591 @default.
• W955105219 hasRelatedWork W2765262925 @default.
• W955105219 hasRelatedWork W2912718090 @default.
• W955105219 hasRelatedWork W2946667327 @default.
• W955105219 hasRelatedWork W2951895853 @default.
• W955105219 hasRelatedWork W4306381808 @default.
• W955105219 hasRelatedWork W4318671286 @default.
• W955105219 hasRelatedWork W4377982552 @default.
• W955105219 hasVolume "1;12" @default.

• next